Newsmax TV & Webwww.newsmax.comFREE - In Google Play
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
Tags: a | fib | patients | warfarin | blood | thinner

More A-Fib Patients Take New Blood Thinners Instead of Warfarin: Study

By    |   Wednesday, 22 July 2015 02:19 PM EDT

A class of popular new clot-busting drugs is behind a dramatic rise in people being treated for heart-rhythm problems, a new study suggests.

The findings, published in the American Journal of Medicine, show the growing number of patients treated for atrial fibrillation is largely driven by the popularity of new direct oral anticoagulants (DOAC) — blood thinners that have been heavily advertised as simple to use.

Their use has tripled from 2013-2014, according to the new study by the University of Michigan Frankel Cardiovascular Center.

Across the United States doctors treated more than 2.83 million patients in the last quarter of 2014 — up from 2.05 million at the start of 2009 — for use of anticoagulants. By comparison, warfarin therapy visits declined between 2009 and 2014.

Last year, 57 percent of anticoagulant visits were related to warfarin use compared to 43 percent related to DOACs, according to the study.

"The data provides a promising outlook about atrial fibrillation which is known for being undertreated," says lead researcher Geoffrey Barnes, M.D., a cardiologist at the University of Michigan Health System and researcher at the Institute for Healthcare Policy and Innovation.

"When we don't treat atrial fibrillation, patients are at risk for stroke. By seeking treatment, patients set themselves up for better outcomes."

Dabigatran accounted for the majority of prescriptions for DOACs from 2010-2012, but as other drugs have come on the market, rivaroxaban (Xarelto) has become the most commonly prescribed oral anticoagulant during atrial fibrillation office visits, the study showed.

© 2023 NewsmaxHealth. All rights reserved.

New clot-busting drugs are behind a dramatic rise in people being treated for heart-rhythm problems, a new study suggests.
a, fib, patients, warfarin, blood, thinner
Wednesday, 22 July 2015 02:19 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
Find Your Condition
Get Newsmax Text Alerts

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved
© Newsmax Media, Inc.
All Rights Reserved